ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Metrion Biosciences Ltd

Metrion Biosciences Ltd is an active company incorporated on 3 July 2015 with the registered office located in Cambridge, Cambridgeshire. Metrion Biosciences Ltd was registered 10 years ago.
Status
Active
Active since incorporation
Company No
09669815
Private limited company
Age
10 years
Incorporated 3 July 2015
Size
Small
Turnover is under £15M
Balance sheet is under £7.5M
Under 50 employees
Confirmation
Submitted
Dated 2 July 2025 (2 months ago)
Next confirmation dated 2 July 2026
Due by 16 July 2026 (10 months remaining)
Last change occurred 2 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Small
Next accounts for period 31 December 2025
Due by 30 September 2026 (1 year remaining)
Contact
Address
First Floor, Building 2 Granta Centre, Granta Park
Great Abington
Cambridge
CB21 6AL
United Kingdom
Same address for the past 4 years
Telephone
01223919100
Email
Unreported
People
Officers
9
Shareholders
38
Controllers (PSC)
1
Secretary • Director • Chief Financial Officer • British • Lives in UK • Born in Aug 1971
Director • Operating Director • British • Lives in England • Born in Apr 1963
Director • British • Lives in UK • Born in Jul 1969
Director • Scientist • British • Lives in UK • Born in Jul 1974
Director • British • Lives in UK • Born in Dec 1972
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Enterprise Therapeutics Ltd
Dr John William Ford is a mutual person.
Active
Greyford Consulting Limited
Dr John William Ford is a mutual person.
Active
Metrion Pharma Ltd
Andrew Paul Southan is a mutual person.
Active
Enterprise Therapeutics Holdings Limited
Dr John William Ford is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2016–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£1.92M
Decreased by £1.35M (-41%)
Turnover
£5.53M
Decreased by £506.76K (-8%)
Employees
46
Decreased by 3 (-6%)
Total Assets
£7.44M
Increased by £147.02K (+2%)
Total Liabilities
-£1.63M
Increased by £14.4K (+1%)
Net Assets
£5.81M
Increased by £132.62K (+2%)
Debt Ratio (%)
22%
Decreased by 0.24% (-1%)
Latest Activity
Confirmation Submitted
2 Months Ago on 7 Jul 2025
Small Accounts Submitted
2 Months Ago on 16 Jun 2025
Clare Louise Rutty Details Changed
6 Months Ago on 24 Feb 2025
Lee Robert Patterson Appointed
9 Months Ago on 6 Dec 2024
Andrew Paul Southan Resigned
9 Months Ago on 30 Nov 2024
Small Accounts Submitted
1 Year 1 Month Ago on 6 Aug 2024
Confirmation Submitted
1 Year 2 Months Ago on 5 Jul 2024
Maya Caroline Ward Resigned
1 Year 8 Months Ago on 18 Dec 2023
Steven Alexander Anderson Carle Appointed
1 Year 8 Months Ago on 18 Dec 2023
Clare Louise Rutty Details Changed
1 Year 9 Months Ago on 4 Dec 2023
Get Credit Report
Discover Metrion Biosciences Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 2 July 2025 with updates
Submitted on 7 Jul 2025
Director's details changed for Clare Louise Rutty on 4 December 2023
Submitted on 4 Jul 2025
Director's details changed for Clare Louise Rutty on 24 February 2025
Submitted on 4 Jul 2025
Accounts for a small company made up to 31 December 2024
Submitted on 16 Jun 2025
Statement of capital following an allotment of shares on 11 February 2025
Submitted on 21 Feb 2025
Termination of appointment of Andrew Paul Southan as a director on 30 November 2024
Submitted on 10 Dec 2024
Appointment of Lee Robert Patterson as a director on 6 December 2024
Submitted on 10 Dec 2024
Accounts for a small company made up to 31 December 2023
Submitted on 6 Aug 2024
Statement of capital following an allotment of shares on 1 August 2024
Submitted on 6 Aug 2024
Confirmation statement made on 2 July 2024 with updates
Submitted on 5 Jul 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year